SYDNEY, Dec 16 (Reuters) - Shares in Australian pharmaceutical company Mayne Pharma Group Ltd MYX.AX fell more than 16 percent on Friday, after opening 8 percent down, on news that 20 U.S states had filed legal proceedings against the company, alleging illegal conspiracies that raised prices on two common generic drugs.